These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32686253)

  • 1. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study.
    Vecchié A; Bonaventura A; Meessen J; Novelli D; Minetti S; Elia E; Ferrara D; Ansaldo AM; Scaravilli V; Villa S; Ferla L; Caironi P; Latini R; Carbone F; Montecucco F;
    J Intern Med; 2021 Feb; 289(2):179-192. PubMed ID: 32686253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock.
    Atreya MR; Whitacre BE; Cvijanovich NZ; Bigham MT; Thomas NJ; Schwarz AJ; Weiss SL; Fitzgerald JC; Allen GL; Lutfi R; Nowak JE; Quasney MW; Shah AS; Wong HR
    Crit Care Med; 2020 Oct; 48(10):1513-1520. PubMed ID: 32769621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source of Circulating Pentraxin 3 in Septic Shock Patients.
    Albert Vega C; Mommert M; Boccard M; Rimmelé T; Venet F; Pachot A; Leray V; Monneret G; Delwarde B; Brengel-Pesce K; Mallet F; Trouillet-Assant S
    Front Immunol; 2018; 9():3048. PubMed ID: 30687307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock.
    Jie H; Li Y; Pu X; Ye J
    Am J Med Sci; 2017 Mar; 353(3):242-246. PubMed ID: 28262210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions.
    Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS
    BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
    Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
    Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
    Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
    Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of resistin and myeloperoxidase in severe sepsis and septic shock: Results from the ALBIOS trial.
    Bonaventura A; Carbone F; Vecchié A; Meessen J; Ferraris S; Beck E; Keim R; Minetti S; Elia E; Ferrara D; Ansaldo AM; Novelli D; Caironi P; Latini R; Montecucco F
    Eur J Clin Invest; 2020 Oct; 50(10):e13333. PubMed ID: 32585739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
    Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
    Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock.
    Tian R; Wang X; Pan T; Li R; Wang J; Liu Z; Chen E; Mao E; Tan R; Chen Y; Liu J; Qu H
    Scand J Immunol; 2019 Dec; 90(6):e12823. PubMed ID: 31489646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients.
    Leung AKK; Genga KR; Topchiy E; Cirstea M; Shimada T; Fjell C; Russell JA; Boyd JH; Walley KR
    Sci Rep; 2019 Jul; 9(1):10588. PubMed ID: 31332258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis.
    Walley KR; Boyd JH; Kong HJ; Russell JA
    Crit Care Med; 2019 Mar; 47(3):463-466. PubMed ID: 30394916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early osteopontin levels predict mortality in patients with septic shock.
    Carbone F; Bonaventura A; Vecchiè A; Meessen J; Minetti S; Elia E; Ferrara D; Ansaldo AM; Tulli G; Guarducci D; Rossi N; Bona F; Ferrari M; Caironi P; Latini R; Montecucco F
    Eur J Intern Med; 2020 Aug; 78():113-120. PubMed ID: 32409206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
    Genga KR; Lo C; Cirstea MS; Leitao Filho FS; Walley KR; Russell JA; Linder A; Francis GA; Boyd JH
    EBioMedicine; 2018 Dec; 38():257-264. PubMed ID: 30473376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.